Rivaroxaban has the highest cumulative probability of any inpatient major bleeding. The overall Log-rank is p<0.0001.</p
Sensitivity analysis using only patients initiated with standard dosage adjusted hazard ratios (HRs)...
<p>Percent survival of major bleeding complications by Kaplan-Meier life table method, stratified to...
Adjusted hazard ratios (HRs) and 95% confidence intervals (CIs) for any, major, and clinically relev...
Univariate and multivariate analysis of the associations between major bleeding and lesion size, tim...
Rates, management, and outcome of rivaroxaban bleeding in daily care: results from the Dresden NOAC ...
Sensitivity analysis—Inverse probability treatment weighting IPTW analyses: Adjusted hazard ratios (...
Adjusted hazard ratios (HRs) and 95% confidence intervals (CIs) for inpatient major bleeding during ...
Incidences of major bleeding by timing to start rivaroxaban and cerebral infarct size.</p
Rivaroxaban is a new oral anticoagulant (NOAC) that can be prescribed in a fixed dose, making regula...
Objectives Outpatient treatment of acute venous thromboembolism (VTE) requires the selection of pati...
Objectives Outpatient treatment of acute venous thromboembolism (VTE) requires the selection of pati...
Objectives Outpatient treatment of acute venous thromboembolism (VTE) requires the selection of pati...
<p>Kaplan-Meier estimates of cumulative hazard of major bleeding events with the use of unfractionat...
Serious bleeding events have been frequently described in patients taking direct oral anticoagulants...
New data of the real clinical practice confirms low incidence of major bleeding when using rivaroxab...
Sensitivity analysis using only patients initiated with standard dosage adjusted hazard ratios (HRs)...
<p>Percent survival of major bleeding complications by Kaplan-Meier life table method, stratified to...
Adjusted hazard ratios (HRs) and 95% confidence intervals (CIs) for any, major, and clinically relev...
Univariate and multivariate analysis of the associations between major bleeding and lesion size, tim...
Rates, management, and outcome of rivaroxaban bleeding in daily care: results from the Dresden NOAC ...
Sensitivity analysis—Inverse probability treatment weighting IPTW analyses: Adjusted hazard ratios (...
Adjusted hazard ratios (HRs) and 95% confidence intervals (CIs) for inpatient major bleeding during ...
Incidences of major bleeding by timing to start rivaroxaban and cerebral infarct size.</p
Rivaroxaban is a new oral anticoagulant (NOAC) that can be prescribed in a fixed dose, making regula...
Objectives Outpatient treatment of acute venous thromboembolism (VTE) requires the selection of pati...
Objectives Outpatient treatment of acute venous thromboembolism (VTE) requires the selection of pati...
Objectives Outpatient treatment of acute venous thromboembolism (VTE) requires the selection of pati...
<p>Kaplan-Meier estimates of cumulative hazard of major bleeding events with the use of unfractionat...
Serious bleeding events have been frequently described in patients taking direct oral anticoagulants...
New data of the real clinical practice confirms low incidence of major bleeding when using rivaroxab...
Sensitivity analysis using only patients initiated with standard dosage adjusted hazard ratios (HRs)...
<p>Percent survival of major bleeding complications by Kaplan-Meier life table method, stratified to...
Adjusted hazard ratios (HRs) and 95% confidence intervals (CIs) for any, major, and clinically relev...
DOI
Add to ORKG